2-((4-(hydroxymethyl)phenyl)amino)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one

ID: ALA5205537

PubChem CID: 168297351

Max Phase: Preclinical

Molecular Formula: C16H10F3N3O4S

Molecular Weight: 397.33

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1nc(Nc2ccc(CO)cc2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12

Standard InChI:  InChI=1S/C16H10F3N3O4S/c17-16(18,19)9-5-11-13(12(6-9)22(25)26)27-15(21-14(11)24)20-10-3-1-8(7-23)2-4-10/h1-6,23H,7H2,(H,20,21,24)

Standard InChI Key:  NCGLVHPRTHJAGC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.7185    0.6205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0041    0.2078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7153    0.6239    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4281    0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4281   -0.6235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132   -1.0351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0041   -0.6217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132   -1.8600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1451   -1.0341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8611   -0.6235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8611    0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1451    0.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1451    1.4498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8596    1.8622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4308    1.8622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5749   -1.0371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5737   -1.8622    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2895   -0.6245    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2895   -1.4496    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4332    0.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1478    0.6207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8601    0.2090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8603   -0.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1502   -1.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4334   -0.6205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5749   -1.0289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2895   -0.6163    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  2  7  2  0
  6  8  2  0
  5  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  4  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 10 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
  1 20  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 20 25  1  0
 23 26  1  0
 26 27  1  0
M  CHG  2  13   1  15  -1
M  END

Alternative Forms

  1. Parent:

    ALA5205537

    ---

Associated Targets(non-human)

Mycolicibacterium vaccae (371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.33Molecular Weight (Monoisotopic): 397.0344AlogP: 3.82#Rotatable Bonds: 4
Polar Surface Area: 105.36Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -1.39

References

1. Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F..  (2022)  Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones.,  65  (9.0): [PMID:35502994] [10.1021/acs.jmedchem.2c00098]

Source